GSA Capital Partners’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-14,000
| Closed | -$85K | – | 2069 |
|
|
2018
Q1 | $85K | Sell |
14,000
-53,200
| -79% | -$323K | ﹤0.01% | 1540 |
|
|
2017
Q4 | $646K | Buy |
67,200
+30,000
| +81% | +$288K | 0.04% | 820 |
|
|
2017
Q3 | $330K | Sell |
37,200
-11,400
| -23% | -$101K | 0.02% | 1194 |
|
|
2017
Q2 | $615K | Sell |
48,600
-32,400
| -40% | -$410K | 0.04% | 883 |
|
|
2017
Q1 | $851K | Buy |
81,000
+34,300
| +73% | +$360K | 0.05% | 749 |
|
|
2016
Q4 | $430K | Sell |
46,700
-46,200
| -50% | -$425K | 0.03% | 1102 |
|
|
2016
Q3 | $1.1M | Buy |
+92,900
| New | +$1.1M | 0.06% | 563 |
|
|
2016
Q2 | – | Sell |
-94,878
| Closed | -$1.52M | – | 2000 |
|
|
2016
Q1 | $1.52M | Sell |
94,878
-131,834
| -58% | -$2.11M | 0.1% | 313 |
|
|
2015
Q4 | $6.49M | Buy |
226,712
+199,252
| +726% | +$5.7M | 0.32% | 12 |
|
|
2015
Q3 | $782K | Sell |
27,460
-2,000
| -7% | -$57K | 0.04% | 837 |
|
|
2015
Q2 | $1.06M | Sell |
29,460
-110
| -0.4% | -$3.95K | 0.04% | 839 |
|
|
2015
Q1 | $859K | Buy |
+29,570
| New | +$859K | 0.03% | 989 |
|